Comparison

7BIO European Partner

Item no. TMO-T22012-200mg
Manufacturer TargetMol
CASRN 916440-85-2
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,9977
Formula C16H10BrN3O2
Smiles O\N=C1\C(\Nc2ccccc\12)=C1\C(=O)Nc2c1cccc2Br
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias FLT,DYRK,Aurora Kinase
Shipping Condition Cool pack
Available
Manufacturer - Targets
DYRK|||Aurora Kinase|||FLT
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
356.17
Description
7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Cell Cycle/Checkpoint
Bioactivity
7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close